What is the appropriate evaluation and management for a patient with a dilated right atrium and right ventricle?

Evaluation and Management of Dilated Right Atrium and Right Ventricle

Begin with transthoracic echocardiography (TTE) to determine the underlying etiology—distinguishing between volume overload, pressure overload, primary myocardial disease, or tricuspid regurgitation—as this determines all subsequent management decisions 1.

Initial Diagnostic Approach

Transthoracic Echocardiography Assessment

Perform comprehensive TTE to evaluate:

• RV size and function: Look for RV dilation, systolic dysfunction (TAPSE <16 mm indicates poor function), and ventricular interdependence (D-shaped LV from septal flattening) 2
• Tricuspid valve: Assess for severe TR using vena contracta ≥7 mm, EROA ≥0.4 cm², regurgitant volume ≥45 mL/beat, hepatic vein systolic flow reversal 1
• Pulmonary pressures: Estimate systolic PAP and assess for pulmonary hypertension
• RA pressure: Elevated RA pressure with prominent c-V waves suggests severe TR 1
• Left heart: Rule out left-sided disease causing secondary right heart failure 2

Advanced Imaging When Needed

Obtain cardiac MRI as the preferred method to assess RV volumes and function when TTE is inadequate or discordant with clinical findings 1. Consider 3D echocardiography and RV free wall longitudinal strain for additional functional assessment 1.

Invasive Hemodynamic Assessment

Perform right heart catheterization when clinical and non-invasive data are discordant or inadequate (Class IIa) 1. This measures:

• Cardiac index
• Right-sided diastolic pressures
• Systolic PAP and pulmonary vascular resistance
• RA pressure

This is critical because declining PAP in the setting of persistently elevated PVR is an ominous finding indicating decompensated right heart failure 2.

Pathophysiology Recognition

Decompensation Indicators

Watch for these high-risk features:

• RV dilation compressing the LV (ventricular interdependence): This impairs LV filling through pericardial constraint, reducing cardiac output independent of RV forward flow 2
• Rising RA pressure with declining cardiac output: Indicates transition from compensated to decompensated state 2
• TAPSE <16 mm: Associated with 2.4-fold increased mortality risk 2

Common Etiologies to Differentiate

• Volume overload: Atrial septal defect, tricuspid regurgitation, anomalous pulmonary venous return 3
• Pressure overload: Pulmonary hypertension, pulmonary embolism, pulmonary stenosis 3
• Primary myocardial disease: Arrhythmogenic RV cardiomyopathy, RV infarction 3
• Idiopathic RA dilation: Rare entity associated with atrial arrhythmias, thrombus formation, and can progress to heart failure 4, 5

Management Strategy

For Severe Tricuspid Regurgitation

Primary TR with symptoms and right heart failure:

• TV surgery is beneficial to reduce symptoms and recurrent hospitalizations (Class IIa) 1
• European guidelines give stronger recommendation (Class I) for symptomatic patients without severe RV dysfunction 1

Secondary TR with refractory right heart failure:

• TV surgery can be beneficial when due to annular dilation in absence of pulmonary hypertension or left-sided disease (Class IIa) 1
• Consider surgery if symptomatic with RV dilation but without severe RV/LV dysfunction or severe pulmonary vascular disease 1

Asymptomatic patients:

• Consider TV surgery for progressive RV dilation or systolic dysfunction (Class IIb) 1

Medical Management Principles

For acute RV dysfunction:

• Optimize preload carefully: RV requires adequate preload, but excessive volume worsens ventricular interdependence 2
• Reduce RV afterload: Treat underlying pulmonary hypertension if present
• Support contractility: Consider inotropes if RV systolic dysfunction present 6, 7
• Maintain coronary perfusion: Combination of RV systolic and biventricular diastolic dysfunction impairs coronary blood flow 2

Critical Pitfalls to Avoid

• Do not assume reduced LV filling is from poor RV output: It's more likely from RV dilation with pericardial constraint causing ventricular interdependence 2
• Do not miss idiopathic RA dilation: Though rare, requires antiplatelet therapy and consideration of reduction atrioplasty for rapid growth, compression, or refractory arrhythmias 4, 5
• Do not delay intervention in progressive disease: RVD prevalence in HFrEF is 48% and universally associated with increased mortality 2

Surveillance and Follow-up

Monitor for:

• Atrial arrhythmias: Common with RA dilation, may require rhythm control 4, 5
• Thrombus formation: Particularly with idiopathic RA dilation, warrants anticoagulation consideration 5
• Progressive RV dysfunction: Serial TAPSE measurements, exercise capacity assessment 2
• Symptoms of right heart failure: Peripheral edema, ascites, hepatic congestion 2